☆ 4.6 Review

The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Hematology

Plasma microparticles of intubated COVID-19 patients cause endothelial cell death, neutrophil adhesion and netosis, in a phosphatidylserine-dependent manner

Yohann Garnier et al.

Summary: COVID-19 patients exhibit increased concentration and size of platelet-derived and endothelial cell-derived microparticles (MPs). These MPs trigger cell death and induce overexpression of adhesion molecules, leading to increased neutrophil adhesion and DNA trap release. Preincubation of these MPs can attenuate their cytotoxicity and induction. The study suggests that MPs play a key role in COVID-19 pathophysiology and annexin A5 may have therapeutic potential.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Severe Pulmonary Hypertension: An Important Sequel After Severe Post-Acute COVID-19 Pneumonia

Guillermo Cueto-Robledo et al.

CURRENT PROBLEMS IN CARDIOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial

Charlotte A. Bradbury et al.

Summary: The study results showed that among critically ill patients with COVID-19, treatment with an antiplatelet agent compared with no antiplatelet agent did not significantly improve the number of organ support-free days within 21 days. The use of antiplatelet therapy in critically ill patients with COVID-19 did not show significant benefits.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Infectious Diseases

Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study

Michela Antonelli et al.

Summary: Despite the high efficacy of COVID-19 vaccines, some individuals still become infected with SARS-CoV-2 post-vaccination. Risk factors for post-vaccination infection include frailty in older adults, living in deprived areas, and obesity. Vaccination is associated with reduced odds of severe symptoms and long-duration illness. The findings suggest the importance of targeting at-risk populations and maintaining infection control measures even in vaccinated individuals.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication

Qin Ning et al.

Summary: This review provides an overview of the extrapulmonary complications of COVID-19, exploring their pathogenesis and potential therapeutic targets, and highlights their clinical implications for disease progression and treatment strategies.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Add to Collection

Review Medicine, General & Internal

Cytokine storm syndrome in coronavirus disease 2019: A narrative review

Y. -M. Gao et al.

Summary: Cytokine storm syndrome (CSS) is a critical clinical condition often seen in COVID-19 patients, characterized by a cascade of cytokine activation and systemic inflammation. Current understanding of the pathogenesis and treatment options for CSS has been deepened.

JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Review Chemistry, Applied

Comprehensive Landscape of Heparin Therapy for COVID-19

Chen Shi et al.

Summary: Heparin may have multiple effects in managing COVID-19, including anticoagulant, anti-inflammatory, and direct antiviral activities. However, challenges and adverse effects of using heparin therapy for SARS-CoV-2 infection need to be considered.

CARBOHYDRATE POLYMERS (2021)

Add to Collection

Article Cell Biology

Single-cell transcriptomic atlas of primate cardiopulmonary aging

Shuai Ma et al.

Summary: The research indicates that aging is associated with increased systemic inflammation and compromised virus defense in the cardiopulmonary system. With age, expression of the SARS-CoV-2 receptor ACE2 increases, while the accumulation of the cytokine IL7 induces ACE2 expression. Treatment with vitamin C can block IL7-induced ACE2 expression, suggesting that geroprotective strategies may reduce the severity of COVID-19 in the elderly.

CELL RESEARCH (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae

Leonardo Italia et al.

Summary: The relationship between heart failure (HF) and coronavirus disease 2019 (COVID-19) is complex, with COVID-19 pandemic causing a reduction in HF hospitalizations but increasing HF mortality. Pre-existing HF is a risk factor for a more severe clinical course of COVID-19, and myocardial injury is common in COVID-19 patients, potentially leading to HF. Further research is needed to fully understand the long-term consequences of cardiac involvement in COVID-19 patients.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Biology

Associations between the Severity of the Post-Acute COVID-19 Syndrome and Echocardiographic Abnormalities in Previously Healthy Outpatients Following Infection with SARS-CoV-2

Cristina Tudoran et al.

Summary: The study revealed that around a quarter of patients with post-acute COVID-19 syndrome had cardiac abnormalities, which were significantly correlated with the severity of COVID-19, the number of persisting symptoms, and the quality of life. This syndrome lasts for a long duration and has a significant impact on the functional status and quality of life of the affected individuals.

BIOLOGY-BASEL (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

COVID-19 Severity: Lung-Heart Interplay

Gayatri Puri et al.

Summary: The novel coronavirus infection, COVID-19, caused by SARS-CoV-2, primarily affects the pulmonary system and is associated with interactions between lung and heart. While most patients exhibit mild symptoms, a proportion experience severe illness, particularly those with cardiovascular complications and diabetes, leading to increased mortality. Effective treatment and management strategies for COVID-19 should focus on understanding and addressing these interactions.

CURRENT CARDIOLOGY REVIEWS (2021)

Add to Collection

Article Hematology

Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis

Matthew L. Meizlish et al.

Summary: In this study of hospitalized COVID-19 patients, intermediate-dose anticoagulation and aspirin treatment were each associated with a significantly lower cumulative incidence of in-hospital death as shown by propensity score matching and multivariable regression analysis.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells

Ian R. McCracken et al.

CIRCULATION (2021)

Add to Collection

Article Respiratory System

Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial

Thomas Sonnweber et al.

Summary: A study found that some COVID-19 patients still experienced persistent symptoms and lung function impairment 100 days after the onset of the disease, but there was significant improvement in symptoms and cardiopulmonary status over time.

EUROPEAN RESPIRATORY JOURNAL (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Mechanisms of COVID-19-induced heart failure: a short review

Ernest A. Adeghate et al.

Summary: The global pandemic of COVID-19 caused by SARS-CoV-2 has resulted in over 42.5 million infections and 1.15 million deaths, significantly impacting public health and the economy. In addition to severe respiratory distress syndrome, COVID-19 can also lead to heart failure through various mechanisms, requiring different approaches such as social distancing, drug therapy, and vaccine development to mitigate its impact.

HEART FAILURE REVIEWS (2021)

Add to Collection

Article Medicine, Research & Experimental

Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory

Maurizio Carcaterra et al.

Summary: The COVID-19 pandemic requires global collaborative efforts to define preventive and treatment strategies. One major challenge is the high number of patients requiring advanced respiratory support, with inflammation potentially playing a key role. Future therapeutic efforts may focus on targeting Type II alveolar cells to address the molecular pathogenic drivers associated with their dysfunction.

MEDICAL HYPOTHESES (2021)

Add to Collection

Article Surgery

The effectiveness of early anticoagulant treatment in Covid-19 patients

Yakup Arslan et al.

Summary: This study evaluated the effects of early anticoagulant treatment in hospitalized Covid-19 patients. Results showed that LMWH-treated patients had higher coagulation markers and the inflammatory markers were significantly increased in LMWH-untreated patients. Additionally, comorbidities were more common in LMWH-treated patients, and ICU transfer and longer hospital stays were more common in LMWH-untreated patients.

PHLEBOLOGY (2021)

Add to Collection

Review Critical Care Medicine

Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19

Ranju T. Dhawan et al.

Summary: COVID-19 is associated with pulmonary thrombosis and thromboembolism, potentially leading to pulmonary fibrotic damage and long-term consequences. A proactive follow-up strategy is needed to evaluate residual clot burden, small vessel injury, and potential hemodynamic sequelae. A nuanced and physiological approach to follow-up imaging is crucial for informing therapeutic strategies in case of clinically significant pulmonary vascular sequelae.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

COVID-19-convalescence phase unmasks a silent myocardial infarction due to coronary plaque rupture

Carsten Tschoepe et al.

Summary: The increased risk of cardiovascular complications during and post-COVID-19 infection is more recognized, including myocarditis, arrhythmias, and myocardial infarctions. Mechanisms leading to these complications involve direct virus-induced injuries, potential thrombotic and inflammatory-induced mechanisms. Myocardial infarction might be an important differential diagnosis to consider in deteriorating patients with COVID-19.

ESC HEART FAILURE (2021)

Add to Collection

Article Respiratory System

Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)

Seyed MohammadReza Hashemian et al.

Summary: The study investigated the clinical effect of plasmapheresis on patients with severe COVID-19 and found that it can alleviate inflammatory reactions and improve immune features. Plasmapheresis led to significant reductions in inflammatory cytokine levels, improved oxygen delivery, and increased T cells in patients.

PULMONOLOGY (2021)

Add to Collection

Letter Oncology

Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID-19 outcomes

Maria P. Fernandez-Perez et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Add to Collection

News Item Multidisciplinary Sciences

HOW VACCINATION AFFECTS THE RISK OF LONG COVID

Heidi Ledford

Summary: Coronavirus vaccines help reduce the risk of developing COVID-19, but studies differ on their protective effect against long COVID.

NATURE (2021)

Add to Collection

Article Immunology

Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection

Hassan Tarhini et al.

Summary: This study describes the clinical evolutions and viral mutations of 3 deeply immunocompromised patients, revealing prolonged infectious viral shedding in some cases. Understanding the mechanisms and frequency of prolonged infectiousness is crucial for optimizing isolation policies.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Hematology

Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial

Alejandro J. Gonzalez-Ochoa et al.

Summary: Treatment of COVID-19 patients with sulodexide within 3 days of clinical onset improved clinical outcomes, reducing hospitalization and oxygen requirement, lowering D-dimer and CRP levels, with no increased risk of thromboembolic events, major bleeding, or mortality.

THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Medicine, General & Internal

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

Christopher T. Rentsch et al.

Summary: The study found that early initiation of prophylactic anticoagulation was associated with decreased risk of 30 day mortality among patients hospitalized with covid-19 in the United States, without increasing the risk of serious bleeding events.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Right Ventricular Damage in COVID-19: Association Between Myocardial Injury and COVID-19

Yonghao Lan et al.

Summary: COVID-19, caused by SARS-CoV-2, has led to a global pandemic with significant morbidity and mortality. While primarily affecting the respiratory system, there is also evidence of myocardial injury in severe cases, particularly with right ventricular damage being associated with higher mortality.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

Michelle Sholzberg et al.

Summary: This study aimed to evaluate the effects of therapeutic heparin compared with prophylactic heparin among moderately ill patients with covid-19 admitted to hospital wards. The results of the study may help guide the treatment options for similar patients in the future.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Use of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post-Coronavirus Disease

Donna M. Mancini et al.

Summary: The study showed that circulatory impairment, abnormal ventilatory pattern, and ME/CFS are common in patients with PASC. Dysfunctional breathing, resting hypocapnia, and ME/CFS may contribute to symptoms. CPET is a valuable tool for assessing these patients.

JACC-HEART FAILURE (2021)

Add to Collection

Article Cell Biology

Binding of phosphatidylserine-positive microparticles by PBMC classifies disease severity in COVID-19 patients

Lisa Rausch et al.

Summary: The study revealed an unexpectedly high amount of PS + PMP in the blood of COVID-19 patients, with a strong correlation to disease severity. PS may serve as a novel marker for disease severity, triggering blood coagulation, the complement system, and inflammation, leading to immune dysfunction in COVID-19.

JOURNAL OF EXTRACELLULAR VESICLES (2021)

Add to Collection

Article Infectious Diseases

Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study

Lars Christian Lund et al.

Summary: This study examined prescription drug and healthcare utilization among individuals in Denmark who tested positive for SARS-CoV-2 but did not require hospital admission. The study found that these individuals had a low risk of severe post-acute complications, but showed increases in visits to general practitioners and outpatient hospital visits, indicating potential COVID-19 sequelae.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Post-acute COVID-19 syndrome

Ani Nalbandian et al.

Summary: SARS-CoV-2 is responsible for the COVID-19 pandemic, causing global healthcare crises. Recovery from COVID-19 may lead to persistent symptoms and long-term complications, prompting the need for multidisciplinary care and follow-up for survivors.

NATURE MEDICINE (2021)

Add to Collection

Review Physiology

INFLAMMATION AND THROMBOSIS IN COVID-19 PATHOPHYSIOLOGY: PROTEINASE-ACTIVATED AND PURINERGIC RECEPTORS AS DRIVERS AND CANDIDATE THERAPEUTIC TARGETS

Krishna Sriram et al.

Summary: COVID-19, caused by the SARS-CoV-2 virus, leads to dysregulation of angiotensin signaling which results in increased platelet activation and inflammation. Inhibitors targeting platelet activation or the coagulation cascade may provide potential therapeutic opportunities to treat COVID-19 thromboinflammation.

PHYSIOLOGICAL REVIEWS (2021)

Add to Collection

Article Medicine, General & Internal

Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study

Daniel Ayoubkhani et al.

Summary: Patients discharged from the hospital after COVID-19 were found to have increased rates of multiorgan dysfunction, with higher risk not only limited to the elderly but also varying across ethnic groups.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Chemistry, Medicinal

Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein- Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2

Damir Bojadzic et al.

Summary: In this study, small-molecule inhibitors targeting the protein-protein interaction between SARS-CoV-2 and hACE2 were identified through screening a compound library focused on organic dyes. These inhibitors showed low micromolar activity and effectively blocked the interaction between the virus and cells in experiments. This provides a new approach for the prevention and treatment of viral infections.

ACS INFECTIOUS DISEASES (2021)

Add to Collection

Article Neurosciences

COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease

Che Mohd Nasril Che Mohd Nassir et al.

Summary: COVID-19 infection may contribute to the formation of microthrombi that affect the brain microcirculation, leading to potential CSVD manifestations that could persist beyond the pandemic era.

MOLECULAR NEUROBIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Microbiology

The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19

Kun Li et al.

Summary: The serine protease inhibitors camostat and nafamostat have shown potential in limiting SARS-CoV-2 infection in respiratory tract, with nafamostat exhibiting greater potency. Preclinical evidence supports the efficacy of nafamostat in treating and/or preventing COVID-19 in mice models sensitized to SARS-CoV-2 infection by introducing human ACE2.

MBIO (2021)

Add to Collection

Review Microbiology

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms

Amy D. Proal et al.

Summary: The novel coronavirus SARS-CoV-2 has led to a pandemic of COVID-19, with some patients developing persistent symptoms known as Long COVID or PASC. These patients may have different underlying biological factors driving their symptoms, such as organ damage, persistent viral reservoirs, re-activation of pathogens, and immune dysregulation. Therapeutic approaches may need to be individualized to effectively manage care for specific patients with PASC.

FRONTIERS IN MICROBIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

A Multidisciplinary Approach to Evaluate the Presence of Hepatic and Cardiac Abnormalities in Patients with Post-Acute COVID-19 Syndrome-A Pilot Study

Felix Bende et al.

Summary: The study found that post-acute COVID-19 syndrome may be associated with residual cardiac and hepatic lesions, particularly in more severe cases, putting these patients at risk of developing liver fibrosis and cardiac alterations.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19 A Randomized Clinical Trial

Gustavo A. Ospina-Tascon et al.

Summary: In a randomized clinical trial conducted in Colombia, it was found that high-flow oxygen therapy through a nasal cannula significantly reduced the need for mechanical ventilation support and shortened time to clinical recovery in patients with severe COVID-19 compared to conventional oxygen therapy.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Medicine, Research & Experimental

Endothelial cell infection and dysfunction, immune activation in severe COVID-19

Zhongnan Qin et al.

Summary: The study found that SARS-CoV-2 infection in K18 mice results in severe COVID-19 symptoms, including body weight loss, lung inflammation, perivascular inflammation, and endothelial dysfunction. The infection also leads to immune activation and vascular abnormalities in the lungs, suggesting a possible link between endotheliitis and severe COVID-19 pathogenesis.

THERANOSTICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction

Suowen Xu et al.

Summary: COVID-19 is considered an endothelial disease, with evidence showing that the virus leads to endothelial dysfunction and increased inflammation and monocyte adhesion. Augmenting KLF2 levels can mitigate these effects, improving endothelial function and potentially providing therapeutic benefits for COVID-19-induced vascular disease.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients

Bingwen Eugene Fan et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Add to Collection

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 and the cardiovascular system

Ying-Ying Zheng et al.

NATURE REVIEWS CARDIOLOGY (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Therapeutic strategies for thrombosis: new targets and approaches

Nigel Mackman et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Add to Collection

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Hematology

COVID-19 and its implications for thrombosis and anticoagulation

Jean M. Connors et al.

BLOOD (2020)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction

Jesus F. Bermejo-Martin et al.

CARDIOVASCULAR RESEARCH (2020)

Add to Collection

Letter Cardiac & Cardiovascular Systems

ST-Elevation Myocardial Infarction in Patients With COVID-19 Clinical and Angiographic Outcomes

Giulio G. Stefanini et al.

CIRCULATION (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Peng Zhang et al.

CIRCULATION RESEARCH (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Celebrating the 20th Anniversary of the Discovery of ACE2

Mahmoud Gheblawi et al.

CIRCULATION RESEARCH (2020)

Add to Collection

Editorial Material Respiratory System

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge

Xiaoneng Mo et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management

Bhurint Siripanthong et al.

HEART RHYTHM (2020)

Add to Collection

Editorial Material Critical Care Medicine

Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation

Daniel E. Leisman et al.

INTENSIVE CARE MEDICINE (2020)

Add to Collection

Article Critical Care Medicine

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Julie Helms et al.

INTENSIVE CARE MEDICINE (2020)

Add to Collection

Article Immunology

TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib

Dandan Wu et al.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System JACC Review Topic of the Week

Agnieszka Brojakowska et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Article Hematology

Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series

Janice Wang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Medicine, Research & Experimental

CT imaging changes of corona virus disease 2019(COVID-19): a multi-center study in Southwest China

Xiaoming Li et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Add to Collection

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Tao Guo et al.

JAMA CARDIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Letter Medicine, General & Internal

ST-Segment Elevation in Patients with Covid-19-A Case Series

Sripal Bangalore et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Association of Hydroxychloroquine With QTc Interval in Patients With COVID-19

Andrea Mazzanti et al.

CIRCULATION (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications

James D. McFadyen et al.

CIRCULATION RESEARCH (2020)

Add to Collection

Editorial Material Respiratory System

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

Alice Huertas et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Letter Respiratory System

Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection

Justine Frija-Masson et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science

Paul C. Evans et al.

CARDIOVASCULAR RESEARCH (2020)

Add to Collection

Article Cell Biology

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

Xiao-Jin Zhang et al.

CELL METABOLISM (2020)

Add to Collection

Article Hematology

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

George Goshua et al.

LANCET HAEMATOLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Extracellular vesicles: new players in regulating vascular barrier function

Victor Chatterjee et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Electrocardiograhic characteristics in patients with coronavirus infection: A single-center observational study

Yi Li et al.

ANNALS OF NONINVASIVE ELECTROCARDIOLOGY (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cardiac Troponin for Assessment of Myocardial Injury in COVID-19 JACC Review Topic of the Week

Yader Sandoval et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction

Daniel Modin et al.

CIRCULATION (2020)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19

Vinh Q. Chau et al.

CIRCULATION-HEART FAILURE (2020)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 is, in the end, an endothelial disease

Peter Libby et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Article Hematology

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

Grigoris T. Gerotziafas et al.

THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Hematology

Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin

Courtney J. Mycroft-West et al.

THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches

Yuefei Jin et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cardiorenal Tissues Express SARS-CoV-2 Entry Genes and Basigin (BSG/CD147) Increases With Age in Endothelial Cells

Blerina Ahmetaj-Shala et al.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)

Add to Collection

Article Hematology

Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia

Muhua Cao et al.

BLOOD (2017)

Add to Collection

Review Physiology

GETTING TO THE OUTER LEAFLET: PHYSIOLOGY OF PHOSPHATIDYLSERINE EXPOSURE AT THE PLASMA MEMBRANE

Edouard M. Bevers et al.

PHYSIOLOGICAL REVIEWS (2016)

Add to Collection

Article Hematology

Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease

Zhangxiu He et al.

THROMBOSIS AND HAEMOSTASIS (2016)

Add to Collection

Article Hematology

Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation

Florian Langer et al.

THROMBOSIS AND HAEMOSTASIS (2014)

Add to Collection

Article Hematology

Phagocytosis by macrophages and endothelial cells inhibits procoagulant and fibrinolytic activity of acute promyelocytic leukemia cells

Rui Xie et al.

BLOOD (2012)

Add to Collection

Article Multidisciplinary Sciences

Membrane phosphatidylserine regulates surface charge and protein localization

Tony Yeung et al.

SCIENCE (2008)

Add to Collection

Review Biochemistry & Molecular Biology

Phosphatidic acid- and phosphatidylserine-binding proteins

Catherine L. Stace et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)

Add to Collection

Review Biochemistry & Molecular Biology

Metabolism and functions of phosphatidylserine

JE Vance et al.

PROGRESS IN LIPID RESEARCH (2005)

Add to Collection

Review Biochemistry & Molecular Biology

Exposure of platelet membrane phosphatidylserine regulates blood coagulation

BR Lentz

PROGRESS IN LIPID RESEARCH (2003)

Add to Collection

Article Hematology

Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites

JL Shi et al.

BLOOD (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.